Literature DB >> 10669630

Adhesion of monocyte very late antigen-4 to endothelial vascular cell adhesion molecule-1 induces interleukin-1beta-dependent expression of interleukin-6 in endothelial cells.

D Zohlnhöfer1, K Brand, K Schipek, G Pogatsa-Murray, A Schömig, F J Neumann.   

Abstract

In atheroma, T cell-derived interferon-gamma (INF-gamma) stimulates endothelial cells and facilitates recruitment of monocytes. We investigated potential mechanisms by which these interactions could contribute to local and systemic inflammatory responses. Specifically, we analyzed the expression of interleukin (IL)-1beta and IL-6 in both cell types after coculture, the relevant adhesion molecules in this interaction, and transcriptional control by NF-kappaB. We studied coculture of purified peripheral blood monocytes with human umbilical vein endothelial cells (HUVECs), which were stimulated with INF-gamma (10(6) U/L) to model the activated endothelium of atherosclerotic lesions. Coculture of monocytes with activated HUVECs resulted in release of IL-1beta (40. 6+/-3 pg/24 h, P=0.002) and IL-6 (46.6+/-7 ng/24 h, P=0.0015). Electrophoretic mobility gel shift assay and Northern blotting in each cell type separately revealed NF-kappaB activation in both cell types, IL-1beta mRNA expression predominantly in monocytes, and IL-6 mRNA expression predominantly in HUVECs. The endothelial IL-6 release was IL-1-dependent, because it was suppressed by IL-1 receptor antagonist. Experiments with blocking antibodies demonstrated that binding of monocyte very late antigen-4 (VLA-4) to endothelial vascular cell adhesion molecule-1 (VCAM-1) was necessary for the induction of IL-1beta in monocytes. Binding of monocyte VLA-4 to endothelial VCAM-1 induces NF-kappaB activation in both cell types with expression and release of IL-1beta by monocytes, which in turn stimulates endothelial release of IL-6. The beta(1)-integrin-mediated expression of IL-1beta and IL-6 could contribute to local and systemic inflammatory reactions in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669630     DOI: 10.1161/01.atv.20.2.353

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  12 in total

1.  Cell Adhesion Mediated by VCAM-ITGα9 Interactions Enables Lymphatic Development.

Authors:  Yiqing Yang; David Enis; Hui Zheng; Stephanie Chia; Jisheng Yang; Mei Chen; Veerpal Dhillon; Thalia Papayannapoulou; Mark L Kahn
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-05       Impact factor: 8.311

Review 2.  Inflammation in Hypertension.

Authors:  Liang Xiao; David G Harrison
Journal:  Can J Cardiol       Date:  2020-01-24       Impact factor: 5.223

3.  Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells.

Authors:  M H Veltrop; J Thompson; H Beekhuizen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Anti-atherosclerotic effects of Lactobacillus plantarum ATCC 14917 in ApoE-/- mice through modulation of proinflammatory cytokines and oxidative stress.

Authors:  Adil Hassan; Ahmad Ud Din; Yuan Zhu; Kun Zhang; Tianhan Li; Yi Wang; Shangcheng Xu; Haike Lei; Xian Yu; Guixue Wang
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-29       Impact factor: 4.813

Review 5.  PlGF: a multitasking cytokine with disease-restricted activity.

Authors:  Mieke Dewerchin; Peter Carmeliet
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

6.  An Allosteric Shift in CD11c Affinity Activates a Proatherogenic State in Arrested Intermediate Monocytes.

Authors:  Alfredo A Hernandez; Greg A Foster; Stephanie R Soderberg; Andrea Fernandez; Mack B Reynolds; Mable K Orser; Keith A Bailey; Jason H Rogers; Gagan D Singh; Huaizhu Wu; Anthony G Passerini; Scott I Simon
Journal:  J Immunol       Date:  2020-10-14       Impact factor: 5.422

7.  Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.

Authors:  Rodrigo Jacamo; Ye Chen; Zhiqiang Wang; Wencai Ma; Min Zhang; Erika L Spaeth; Ying Wang; Venkata L Battula; Po Yee Mak; Katharina Schallmoser; Peter Ruvolo; Wendy D Schober; Elizabeth J Shpall; Martin H Nguyen; Dirk Strunk; Carlos E Bueso-Ramos; Sergej Konoplev; R Eric Davis; Marina Konopleva; Michael Andreeff
Journal:  Blood       Date:  2014-03-05       Impact factor: 22.113

8.  ERK2 and Akt are negative regulators of insulin and Tumor Necrosis Factor-α stimulated VCAM-1 expression in rat aorta endothelial cells.

Authors:  Gregory B Pott; Mark Tsurudome; Nadia Bamfo; Marc L Goalstone
Journal:  J Inflamm (Lond)       Date:  2016-02-25       Impact factor: 4.981

9.  Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease.

Authors:  Samaneh Enayati; Soroush Seifirad; Parvin Amiri; Milad Abolhalaj; Mahsa Mohammad-Amoli
Journal:  ARYA Atheroscler       Date:  2015-09

10.  Human papillomavirus e7 oncoprotein transgenic skin develops an enhanced inflammatory response to 2,4-dinitrochlorobenzene by an arginase-1-dependent mechanism.

Authors:  D Mittal; I H Frazer; L S Tran; A-S Bergot; S R Mattarollo
Journal:  J Invest Dermatol       Date:  2014-04-14       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.